Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice Webcast (2023)

Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice (2023) is an exciting new educational initiative to update urologists on the most recent clinical guideline for the management of advanced prostate cancer. This course features a Moderator and three other subject matter experts engaging in an interactive, interview-style presentation and discussion.  

Based on the findings from the latest AUA needs assessment in advanced prostate cancer, the AUA has developed this new series of virtual courses to update urologists on the most recent clinical guideline for the management of advanced prostate cancer. This course will review the evidence-based guideline statements that were developed to provide a rational basis for evidence-based treatment of advanced prostate cancer, including disease stages that range from prostate-specific antigen (PSA) recurrence after exhaustion of local treatment options to widespread metastatic disease. 

The webcast will be made available on AUAUniversity and AUA’s YouTube channel for on‐demand viewing for up to one year. Additionally, the audio of the virtual course will be released as an episode on AUA’s very popular podcast.


This educational series is supported by independent educational grants from: 

  • Astellas and Pfizer, Inc.

  • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

  • Lantheus Medical Imaging

  • Merck & Co., Inc.

  • Pfizer, Inc.


Target Audience

  • Urologists
  • Residents

Learning Objectives

After participating in this educational activity, participants will be able to:

  1. Cite recommendations within the newly amended AUA/SUO Advanced Prostate Cancer Guideline.
  2. Assess the impact of newly approved agents on the management of men with Advanced Prostate Cancer.
  3. Define M0 CRPC and the treatment options.
  4. Identify clinically meaningful endpoints in clinical trials of patients with M0 CRPC.
  5. Describe gaps in the knowledge for treatment and sequencing of agents in the management of CRPC.
  6. Discuss treatment intensification in mHSPC.
  7. Discuss challenges in incorporating AUA/SUO Advanced Prostate Cancer Guideline and management of advanced mHSPC and CRPC into community practice.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
Course expires: 


For a full listing of all faculty disclosures, please visit the Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice Live Course page and click on the "Faculty" tab. 


PDF iconEducation Council Disclosures


PDF iconCOI Review Work Group Disclosures

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.


Learners will participate in this online educational activity by taking the pretest, viewing the webcast and/or podcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 1.50 hours

Release Date: September, 2023
Expiration Date: September, 2024


The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The American Urological Association designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.


It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.


All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.


All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:

  • Peer review for valid, evidence-based content by the AUA COI Review Work Group.
  • Attestation that clinical recommendations are evidence-based and free of commercial bias.
  • Introduction of a debate format (point-counterpoint)
  • Inclusion of moderated panel discussion with unbiased moderator
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Divestiture of the relationship by faculty
  • Recusal from controlling relevant aspects of planning
  • Selection of alternative faculty for specific topic


The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Please login or register to take this course.